TABLE 3.
Kd |
||||
---|---|---|---|---|
Site 1 | Sites 2+3 | |||
nm | ||||
hPRL variants | Rat ECD | Human ECD | Rat ECD | Human ECD |
WT | 10.2 ± 1.5 | 6.5 ± 1.0 | 11,000 ± 700 | 32,800 ± 1,800 |
T14P | 12.6 ± 1.3 | ND | 26,300 ± 9,600 | NDa |
Nter | 8.3 ± 0.4 | 5.9 ± 0.1b | 4,900 ± 1,000 | 32,800 ± 14,700 |
PGGA | 6.2 ± 1.4 | ND | 3,700 ± 1,900 | ND |
PGGA-T14P | 3.5 ± 0.2 | ND | 373 ± 72 | ND |
Full-oPL | 1.2 ± 0.1 | 2.1 ± 0.6 | 312 ± 36 | 16,400 ± 2,800 |
a ND, not determined.
b From Ref. 20.